Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Prodrugs based on phospholipid-nucleoside conjugates

Patent ·
OSTI ID:6056069
The invention relates to the production of a single diastereomeric form of a phospholipid araC conjugate as a prodrug.
Assignee:
The United States of America as represented by the United States Department of Energy
Patent Number(s):
US 4471113
OSTI ID:
6056069
Country of Publication:
United States
Language:
English

Similar Records

Prodrugs based on phospholipid-nucleoside conjugates
Patent · Sat Dec 31 23:00:00 EST 1983 · OSTI ID:865159
New prodrugs based on phospholipid-nucleoside conjugates
Patent · Tue Feb 02 23:00:00 EST 1982 · OSTI ID:6710935
Lipid-peptide-polymer conjugates and nanoparticles thereof
Patent · Tue Jun 02 00:00:00 EDT 2015 · OSTI ID:1183465

Related Subjects

550600* -- Medicine
62 RADIOLOGY AND NUCLEAR MEDICINE
CHEMICAL COMPOSITION
CHEMICAL PREPARATION
CHEMOTHERAPY
DISEASES
DRUGS
ESTERS
LIPIDS
NEOPLASMS
ORGANIC COMPOUNDS
ORGANIC PHOSPHORUS COMPOUNDS
PHOSPHOLIPIDS
SYNTHESIS
THERAPY